Search results
Showing results for
The 5-year programme award will support research on the DNA repair mechanisms that protect cancer cells from therapy, informing the development of future therapies.
INTERCEPT-Lynch
INTERCEPT-Lynch: A Phase 1/2 Open-label, Dose-escalation, and Dose-expansion Study of mRNA-4194 in Participants with Lynch Syndrome
Welcome
The Department of Oncology's mission is to improve cancer care through research and teaching. There is strong emphasis on translation, with established infrastructure to develop scientific insights toward clinical appreciation.
VISTA
VISTA: Vaccination with ITOP1 in resectable oesophageal adenocarcinoma – Safety, Tolerability and Anti-Tumour activity

